S

SELLAS Life Sciences Group
D

SLS

3.69000
USD
-0.14
(-3.53%)
مفتوح الان
حجم التداول
84,774
الربح لكل سهم
-0
العائد الربحي
-
P/E
-13
حجم السوق
624,935,035
أصول ذات صلة المقالات

العنوان: SELLAS Life Sciences Group

القطاع: Healthcare
الصناعة: Biotechnology
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.